Oxindole in pathogenesis of hepatic encephalopathy.
Moroni
F
F
Carpenedo
R
R
Venturini
I
I
Baraldi
M
M
Zeneroli
M L
ML
D016022:Case-Control Studies; D003538:Cystamine / Q000009:adverse effects / Q000031:analogs & derivatives*; D006501:Hepatic Encephalopathy / Q000209:etiology* / Q000378:metabolism*; D006801:Humans; D007211:Indoles / Q000097:blood*; D007773:Lactates / Q000009:adverse effects*; D008103:Liver Cirrhosis / Q000150:complications*; D000078183:Oxindoles; D014364:Tryptophan / Q000378:metabolism*
D007211:Indoles; D007773:Lactates; D000078183:Oxindoles; C113063:cystamine bislactamide; C022960:2-oxindole; D014364:Tryptophan; D003538:Cystamine